Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Rankning i aktier #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Aktiekurs
$0.6
Senast synkroniserad: 2024-08-14
Marknadsvärde
$2.09M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
SG
Handel ASLAN Pharmaceuticals Limited (ASLN)

Kategori

Vinst för ASLAN Pharmaceuticals Limited (ASLN)
Vinst i Mar 2024 TTM: $-34.90M
Enligt de senaste finansiella rapporterna från ASLAN Pharmaceuticals Limited är företagets nuvarande vinst $-34.90M. År 2022 hade företaget en vinst på $-51.28M, en minskning jämfört med vinsten år 2021 som var $-31.59M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för ASLAN Pharmaceuticals Limited från 2014 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $-34.90M -20.84%
2023 $-44.09M -14.03%
2022 $-51.28M 62.34%
2021 $-31.59M 86.14%
2020 $-16.97M -63.63%
2019 $-46.66M 10.64%
2018 $-42.17M 3.58%
2017 $-40.71M 352.17%
2016 $-9.00M -32.43%
2015 $-13.33M 80.95%
2014 $-7.36M 0.00%
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
$5.27B -15,214.03%
US
$1.95B -5,689.14%
NL
- -
CH
- -
KR
$3.01B -8,712.20%
BE